Are APOE ε genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?

Translational Psychiatry

Volumn 4, Issue 9, 2014, Pages

  Lyall, D M ^a   Harris, S E ^a   Bastin, M E ^a   Munoz Maniega S ^a   Murray, C ^a   Lutz, M W ^b   Saunders, A M ^b   Roses, A D ^b,c   Del C Valdes Hernandez M ^a   Royle, N A ^a   Starr, J M ^a   Porteous, D J ^a   Wardlaw, J M ^a   Deary, I J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Zinfandel Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON; POLYTHYMIDYLIC ACID; UNCLASSIFIED DRUG;

AGING; ARTICLE; BOOTSTRAPPING; CHILDHOOD; COGNITION; DIFFUSION WEIGHTED IMAGING; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INFORMATION PROCESSING; INTELLIGENCE TEST; LONGITUDINAL STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; TRACTOGRAPHY; VASCULAR DISEASE; WHITE MATTER; WORKING MEMORY; AGED; COGNITIVE DEFECT; DIFFUSION TENSOR IMAGING; FEMALE; GENETIC POLYMORPHISM; GENETICS; MALE; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY;

AGED; AGING; APOLIPOPROTEINS E; COGNITION DISORDERS; DIFFUSION TENSOR IMAGING; FEMALE; GENE FREQUENCY; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; POLY T; POLYMORPHISM, GENETIC; WHITE MATTER;

EID: 84908481281     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.89     Document Type: Article

References (55)

1. Michaud CM, Murray CJ, Bloom BR. Burden of disease-implications for future research. JAMA 2001; 285: 535-539.
2. Henriques JB, Davidson RJ. Left frontal hypoactivation in depression. J Abnorm Psychol 1991; 100: 535-545.
3. Flor-Henry P, Lind JC, Koles ZJ. A source-imaging (low-resolution electromagnetic tomography) study of the EEGs from unmedicated males with depression. Psychiatry Res 2004; 130: 191-207.
4. Armitage R, Roffwarg HP, Rush AJ, Calhoun JS, Purdy DG, Giles DE. Digital period analysis of sleep EEG in depression. Biol Psychiatry 1992; 31: 52-68.
5. Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Grener RH, Selin CE et al. Cerebral metabolic rates for glucose in mood disorders: studies with positron emission tomography and fluorodeoxyglucose F18. Arch Gen Psychiatry 1985; 42: 441-447.
6. Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry 2008; 63: 369-376.
7. Janocha A, Pilecki W, Bolanowski M, Malyszczak K, Salomon E, Laszki-Szczachor K et al. Interhemispheric cerebral asymmetry detected by VEPS in diabetic patients with recognized depression. Neuro Endocrinol Lett 2009; 30: 119-124.
8. Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry 1989; 154: 170-182.
9. Wexler BE. Cerebral laterality and psychiatry: a review of the literature. Am J Psychiatry 1980; 137: 279-291.
10. Ma N, Li L, Shu N, Liu J, Gong G, He Z et al. White matter abnormalities in firstepisode, treatment-naive young adults with major depressive disorder. Am J Psychiatry 2007; 164: 823-826.
11. Aghajani M, Veer IM, van Lang ND, Meens PH, van den Bulk BG, Rombouts SA et al. Altered white-matter architecture in treatment-naive adolescents with clinical depression. Psychol Med 2013; 16: 1-12.
12. Cole J, Chaddock CA, Farmer AE, Aitchison KJ, Simmons A, McGuffin P et al. White matter abnormalities and illness severity in major depressive disorder. Br J Psychiatry 2012; 201: 33-39.
13. Xu K, Jiang W, Ren L, Ouyang X, Jiang Y, Wu F et al. Impaired interhemispheric connectivity in medication-naive patients with major depressive disorder. J Psychiatry Neurosci 2013; 38: 43-48.
14. American Psychiatric Association. Task Force on Electroconvulsive Therapy. The practice of ECT: recommendations for treatment, training and privileging. Convuls Ther 1990; 6: 85-120.
15. Roose SP, Nobler M. ECT and onset of action. J Clin Psychiatry 2001; 62(Suppl 4): 24-26.
16. Husain SS, Kevan IM, Linnell R, Scott AI. Electroconvulsive therapy in depressive illness that has not responded to drug treatment. J Affect Disord 2004; 83: 121-126.
17. Merkl A, Heuser I, Bajbouj M. Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations. Exp Neurol 2009; 219: 20-26.
18. Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P. Efficacy of ECT: a meta-Analysis. Am J Psychiatry 1985; 142: 297-302.
19. Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a metaanalytic review. J ECT 2004; 20: 13-20.
20. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S et al. Resistance to antidepressant medications and short-Term clinical response to ECT. Am J Psychiatry 1996; 153: 985-992.
21. Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med 2007; 357: 1939-1945.
22. Perrin JS, Merz S, Bennett DM, Currie J, Steele DJ, Reid IC et al. Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder. Proc Natl Acad Sci USA 2012; 109: 5464-5468.
23. Zuo XN, Kelly C, Di Martino A, Mennes M, Margulies DS, Bangaru S et al. Growing together and growing apart: regional and sex differences in the lifespan developmental trajectories of functional homotopy. J Neurosci 2010; 30: 15034-15043.
24. Kelly C, Zuo XN, Gotimer K, Cox CL, Lynch L, Brock D et al. Reduced interhemispheric resting state functional connectivity in cocaine addiction. Biol Psychiatry 2011; 69: 684-692.
25. Anderson JS, Druzgal TJ, Froehlich A, DuBray MB, Lange N, Alexander AL et al. Decreased interhemispheric functional connectivity in autism. Cereb Cortex 2011; 21: 1134-1146.
26. Hoptman MJ, Zuo XN, D'Angelo D, Mauro CJ, Butler PD, Milham MP et al. Decreased interhemispheric coordination in schizophrenia: a resting state fMRI study. Schizophr Res 2012; 141: 1-7.
27. Zhou Y, Milham M, Zuo XN, Kelly C, Jaggi H, Herbert J et al. Functional homotopic changes in multiple sclerosis with resting-state functional MR imaging. AJNR Am J Neuroradiol 2013; 34: 1180-1187.
28. Orr C, Morioka R, Behan B, Datwani S, Doucet M, Ivanovic J et al. Altered restingstate connectivity in adolescent cannabis users. Am J Drug Alcohol Abuse 2013; 39: 372-381.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn., American Psychiatric Press: Washington, DC, USA, 1994.
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
31. Chao-Gan Y, Yu-Feng Z. DPARSF: A MATLAB Toolbox for "Pipeline" Data Analysis of Resting-State fMRI. Front Syst Neurosci 2010; 4: 13.
32. Song XW, Dong ZY, Long XY, Li SF, Zuo XN, Zhu CZ et al. REST: a toolkit for restingstate functional magnetic resonance imaging data processing. PLoS One 2011; 6: e25031.
33. Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DCRaichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA 2005; 102: 9673-9678.
34. Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 2012; 59: 2142-2154.
35. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825-841.
36. Yan CG, Cheung B, Kelly C, Colcombe S, Craddock RC, Di Martino A et al. a comprehensive assessment of regional variation in the impact of head micro movements on functional connectomics. Neuroimage 2013; 76: 183-201.
37. Michl P, Meindl T, Meister F, Born C, Engel RR, Reiser M et al. Neurobiological underpinnings of shame and guilt: a pilot fMRI study. Soc Cogn Affect Neurosci 2014; 9: 150-157.
38. Chan SW, Norbury R, Goodwin GM, Harmer CJ. Risk for depression and neural responses to fearful facial expressions of emotion. Br J Psychiatry 2009; 194: 139-145.
39. Smoski MJ, Felder J, Bizzell J, Green SR, Ernst M, Lynch TR et al. fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder. J Affect Disord 2009; 118: 69-78.
40. Abe O, Yamasue H, Kasai K, Yamada H, Aoki S, Inoue H et al. Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiatry Res 2010; 181: 64-70.
41. Kong L, Wu F, Tang Y, Ren L, Kong D, Liu Y et al. Frontal-subcortical volumetric deficits in single episode, medication-naive depressed patients and the effects of 8 weeks fluoxetine treatment: a VBM-DARTEL study. PLoS One 2009; 9: e79055.
42. Lai CH, Wu YT. Frontal-insula gray matter deficits in first-episode medication-naive patients with major depressive disorder. J Affect Disord 2014; 160: 74-79.
43. Wang L, LaBar KS, Smoski M, Rosenthal MZ, Dolcos F, Lynch TR et al. Prefrontal mechanisms for executive control over emotional distraction are altered in major depression. Psychiatry Res 2008; 163: 143-155.
44. Liu CH, Ma X, Wu X, Fan TT, Zhang Y, Zhou FC et al. Resting-state brain activity in major depressive disorder patients and their siblings. J Affect Disord 2013; 149: 299-306.
45. Liu F, Guo W, Liu L, Long Z, Ma C, Xue Z et al. Abnormal amplitude low-frequency oscillations in medication-naive, first-episode patients with major depressive disorder: a resting-state fMRI study. J Affect Disord 2013; 146: 401-406.
46. Li CT, Lin CP, Chou KH, Chen IY, Hsieh JC, Wu CL et al. Structural and cognitive deficits in remitting and non-remitting recurrent depression: a voxel-based morphometric study. Neuroimage 2010; 50: 347-356.
47. Serra-Blasco M, Portella MJ, Gomez-Anson B, de Diego-Adeliño J, Vives-Gilabert Y, Puigdemont D et al. Effects of illness duration and treatment resistance on grey matter abnormalities in major depression. Br J Psychiatry 2013; 202: 434-440.
48. Guo WB, Liu F, Chen JD, Gao K, Xue ZM, Xu XJ et al. Abnormal neural activity of brain regions in treatment-resistant and treatment-sensitive major depressivedisorder: a resting-state fMRI study. J Psychiatr Res 2012; 46: 1366-1373.
49. Wang L, Li K, Zhang Q, Zeng Y, Dai W, Su Y et al. Short-Term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging. Psychol Med 2013; 2013 13: 1-10.
50. Samson AC, Meisenzahl E, Scheuerecker J, Rose E, Schoepf V, Wiesmann M et al. Brain activation predicts treatment improvement in patients with major depressive disorder. J Psychiatr Res 2011; 45: 1214-1222.
51. Bench CJ, Friston KJ, Brown RG, Frackowiak RS, Dolan RJ. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993; 23: 579-590.
52. Fan T, Wu X, Yao L, Dong J. Abnormal baseline brain activity in suicidal and nonsuicidal patients with major depressive disorder. Neurosci Lett 2013; 534: 35-40.
53. Liu F, Hu M, Wang S, Guo W, Zhao J, Li J et al. Abnormal regional spontaneous neural activity in first-episode, treatment-naive patients with late-life depression: a resting-state fMRI study. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39: 326-331.
54. Crowley K, Pickle J, Dale R, Fattal O. A critical examination of bifrontal electroconvulsive therapy: clinical efficacy, cognitive side effects, and directions for future research. J ECT 2008; 24: 268-271.
55. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-Analysis. Biol Psychiatry 2010; 68: 568-577.